Pro Share Advisors LLC Rubius Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.79 - $5.98 $14,167 - $107,239	-17,933 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$4.25 - $10.4 $20,238 - $49,524	-4,762 Reduced 20.98%	17,933 $98,000
Q4 2021 Feb 08, 2022	SELL	$9.68 - $17.74 $22,951 - $42,061	-2,371 Reduced 9.46%	22,695 $221,000
Q3 2021 Nov 12, 2021	SELL	$17.6 - $25.91 $47,132 - $69,386	-2,678 Reduced 9.65%	25,066 $448,000
Q2 2021 Aug 13, 2021	BUY	$22.26 - $28.43 $154,528 - $197,361	6,942 Added 33.37%	27,744 $677,000
Q1 2021 May 14, 2021	BUY	$8.02 - $32.01 $3,023 - $12,067	377 Added 1.85%	20,802 $551,000
Q4 2020 Feb 09, 2021	BUY	$4.23 - $8.73 $12,753 - $26,320	3,015 Added 17.32%	20,425 $155,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $6.25 $1,492 - $2,006	-321 Reduced 1.81%	17,410 $87,000
Q2 2020 Aug 03, 2020	BUY	$4.01 - $6.88 $18,818 - $32,287	4,693 Added 35.99%	17,731 $106,000
Q1 2020 May 15, 2020	SELL	$3.74 - $9.84 $33,495 - $88,127	-8,956 Reduced 40.72%	13,038 $58,000
Q4 2019 Feb 12, 2020	SELL	$7.23 - $14.12 $25,637 - $50,069	-3,546 Reduced 13.88%	21,994 $209,000
Q3 2019 Nov 12, 2019	SELL	$7.85 - $15.75 $11,005 - $22,081	-1,402 Reduced 5.2%	25,540 $200,000
Q2 2019 Aug 13, 2019	SELL	$13.5 - $19.94 $48,829 - $72,122	-3,617 Reduced 11.84%	26,942 $424,000
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $32,949 - $45,960	2,483 Added 8.84%	30,559 $553,000
Q4 2018 Feb 14, 2019	BUY	$13.83 - $22.97 $388,291 - $644,905	28,076 New	28,076 $451,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.